

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.50705825 |
| 2 | * L-phenylalanine catabolic process (GO:0006559) | 7.50705825 |
| 3 | * erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.13135392 |
| 4 | * L-phenylalanine metabolic process (GO:0006558) | 7.13135392 |
| 5 | * aromatic amino acid family catabolic process (GO:0009074) | 6.63412443 |
| 6 | glyoxylate metabolic process (GO:0046487) | 5.96865357 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.94523382 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.94523382 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.94523382 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.84466079 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.74739077 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.72752390 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.60580336 |
| 14 | alpha-linolenic acid metabolic process (GO:0036109) | 5.46045401 |
| 15 | cysteine metabolic process (GO:0006534) | 5.46015193 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 5.26635513 |
| 17 | urea metabolic process (GO:0019627) | 5.25433198 |
| 18 | urea cycle (GO:0000050) | 5.25433198 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.18966373 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.11087655 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.01509830 |
| 22 | protein carboxylation (GO:0018214) | 5.01509830 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.00262033 |
| 24 | serine family amino acid catabolic process (GO:0009071) | 4.98918125 |
| 25 | complement activation, alternative pathway (GO:0006957) | 4.91803825 |
| 26 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.89286992 |
| 27 | bile acid metabolic process (GO:0008206) | 4.86861964 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 4.86797177 |
| 29 | regulation of protein activation cascade (GO:2000257) | 4.85470484 |
| 30 | lysine catabolic process (GO:0006554) | 4.84391769 |
| 31 | lysine metabolic process (GO:0006553) | 4.84391769 |
| 32 | * aromatic amino acid family metabolic process (GO:0009072) | 4.75879360 |
| 33 | homocysteine metabolic process (GO:0050667) | 4.71193788 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 4.59758758 |
| 35 | * alpha-amino acid catabolic process (GO:1901606) | 4.57017648 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 4.54437727 |
| 37 | cellular ketone body metabolic process (GO:0046950) | 4.54213933 |
| 38 | amino-acid betaine metabolic process (GO:0006577) | 4.53942567 |
| 39 | regulation of complement activation (GO:0030449) | 4.52846065 |
| 40 | reverse cholesterol transport (GO:0043691) | 4.46529525 |
| 41 | coenzyme catabolic process (GO:0009109) | 4.43210605 |
| 42 | plasma lipoprotein particle remodeling (GO:0034369) | 4.40623117 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 4.40623117 |
| 44 | macromolecular complex remodeling (GO:0034367) | 4.40623117 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.38338755 |
| 46 | triglyceride homeostasis (GO:0070328) | 4.38338755 |
| 47 | low-density lipoprotein particle clearance (GO:0034383) | 4.30863332 |
| 48 | glutamate metabolic process (GO:0006536) | 4.27536946 |
| 49 | * cellular amino acid catabolic process (GO:0009063) | 4.26290409 |
| 50 | plasma lipoprotein particle clearance (GO:0034381) | 4.24517221 |
| 51 | indolalkylamine metabolic process (GO:0006586) | 4.23673342 |
| 52 | negative regulation of sterol transport (GO:0032372) | 4.22143412 |
| 53 | negative regulation of cholesterol transport (GO:0032375) | 4.22143412 |
| 54 | serine family amino acid metabolic process (GO:0009069) | 4.18423895 |
| 55 | * tyrosine metabolic process (GO:0006570) | 4.18330842 |
| 56 | cellular biogenic amine catabolic process (GO:0042402) | 4.18105124 |
| 57 | amine catabolic process (GO:0009310) | 4.18105124 |
| 58 | phospholipid efflux (GO:0033700) | 4.12927950 |
| 59 | cellular modified amino acid catabolic process (GO:0042219) | 4.11486149 |
| 60 | oxaloacetate metabolic process (GO:0006107) | 4.09166846 |
| 61 | glycine metabolic process (GO:0006544) | 4.08361893 |
| 62 | drug catabolic process (GO:0042737) | 4.07085777 |
| 63 | ethanol oxidation (GO:0006069) | 4.05787109 |
| 64 | serine family amino acid biosynthetic process (GO:0009070) | 4.04815643 |
| 65 | cellular glucuronidation (GO:0052695) | 4.03065334 |
| 66 | bile acid and bile salt transport (GO:0015721) | 4.02181479 |
| 67 | short-chain fatty acid metabolic process (GO:0046459) | 4.02096560 |
| 68 | aldehyde catabolic process (GO:0046185) | 4.01959118 |
| 69 | benzene-containing compound metabolic process (GO:0042537) | 3.99903422 |
| 70 | acetyl-CoA metabolic process (GO:0006084) | 3.99371011 |
| 71 | triglyceride catabolic process (GO:0019433) | 3.95620127 |
| 72 | ketone body metabolic process (GO:1902224) | 3.94637863 |
| 73 | imidazole-containing compound metabolic process (GO:0052803) | 3.93207371 |
| 74 | cholesterol efflux (GO:0033344) | 3.92400305 |
| 75 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.87728433 |
| 76 | omega-hydroxylase P450 pathway (GO:0097267) | 3.86366764 |
| 77 | drug transmembrane transport (GO:0006855) | 3.85922906 |
| 78 | aspartate family amino acid catabolic process (GO:0009068) | 3.84348460 |
| 79 | cofactor catabolic process (GO:0051187) | 3.80852341 |
| 80 | * organic acid catabolic process (GO:0016054) | 3.78942777 |
| 81 | * carboxylic acid catabolic process (GO:0046395) | 3.78942777 |
| 82 | epoxygenase P450 pathway (GO:0019373) | 3.78183309 |
| 83 | fibrinolysis (GO:0042730) | 3.77775344 |
| 84 | urate metabolic process (GO:0046415) | 3.72493493 |
| 85 | neutral lipid catabolic process (GO:0046461) | 3.68776049 |
| 86 | acylglycerol catabolic process (GO:0046464) | 3.68776049 |
| 87 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.67434683 |
| 88 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.67434683 |
| 89 | low-density lipoprotein particle remodeling (GO:0034374) | 3.67272501 |
| 90 | plasma lipoprotein particle assembly (GO:0034377) | 3.64119441 |
| 91 | glucuronate metabolic process (GO:0019585) | 3.64024159 |
| 92 | uronic acid metabolic process (GO:0006063) | 3.64024159 |
| 93 | exogenous drug catabolic process (GO:0042738) | 3.63473593 |
| 94 | cholesterol homeostasis (GO:0042632) | 3.61994234 |
| 95 | heme transport (GO:0015886) | 3.61790016 |
| 96 | regulation of bile acid biosynthetic process (GO:0070857) | 3.61436228 |
| 97 | fatty acid beta-oxidation (GO:0006635) | 3.59540213 |
| 98 | negative regulation of lipase activity (GO:0060192) | 3.59387705 |
| 99 | monocarboxylic acid catabolic process (GO:0072329) | 3.58531845 |
| 100 | negative regulation of blood coagulation (GO:0030195) | 3.58248277 |
| 101 | negative regulation of hemostasis (GO:1900047) | 3.58248277 |
| 102 | fatty acid oxidation (GO:0019395) | 3.57615085 |
| 103 | sterol homeostasis (GO:0055092) | 3.56986564 |
| 104 | regulation of cholesterol homeostasis (GO:2000188) | 3.55910346 |
| 105 | positive regulation of lipid catabolic process (GO:0050996) | 3.53449796 |
| 106 | very long-chain fatty acid metabolic process (GO:0000038) | 3.52372234 |
| 107 | phospholipid homeostasis (GO:0055091) | 3.51513846 |
| 108 | lipid oxidation (GO:0034440) | 3.50929725 |
| 109 | blood coagulation, intrinsic pathway (GO:0007597) | 3.49168558 |
| 110 | regulation of plasminogen activation (GO:0010755) | 3.38266899 |
| 111 | ethanol metabolic process (GO:0006067) | 3.37956898 |
| 112 | NADH metabolic process (GO:0006734) | 3.37746082 |
| 113 | negative regulation of coagulation (GO:0050819) | 3.36659686 |
| 114 | polyketide metabolic process (GO:0030638) | 3.31814451 |
| 115 | doxorubicin metabolic process (GO:0044598) | 3.31814451 |
| 116 | daunorubicin metabolic process (GO:0044597) | 3.31814451 |
| 117 | xenobiotic catabolic process (GO:0042178) | 3.29074974 |
| 118 | positive regulation of blood coagulation (GO:0030194) | 3.27038480 |
| 119 | positive regulation of hemostasis (GO:1900048) | 3.27038480 |
| 120 | acute-phase response (GO:0006953) | 3.08642397 |
| 121 | positive regulation of coagulation (GO:0050820) | 3.06826740 |
| 122 | negative regulation of wound healing (GO:0061045) | 3.05257964 |
| 123 | drug metabolic process (GO:0017144) | 3.03459474 |
| 124 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.01724246 |
| 125 | protein activation cascade (GO:0072376) | 2.99600531 |
| 126 | valine metabolic process (GO:0006573) | 2.97773181 |
| 127 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.94933851 |
| 128 | proline metabolic process (GO:0006560) | 2.91801763 |
| 129 | pentose-phosphate shunt (GO:0006098) | 2.89504304 |
| 130 | proline biosynthetic process (GO:0006561) | 2.86034356 |
| 131 | regulation of sterol transport (GO:0032371) | 2.77947940 |
| 132 | regulation of cholesterol transport (GO:0032374) | 2.77947940 |
| 133 | NADPH regeneration (GO:0006740) | 2.70993654 |
| 134 | tricarboxylic acid metabolic process (GO:0072350) | 2.70830628 |
| 135 | fatty acid catabolic process (GO:0009062) | 2.68435061 |
| 136 | primary alcohol metabolic process (GO:0034308) | 2.63809689 |
| 137 | fatty acid homeostasis (GO:0055089) | 2.63298165 |
| 138 | tetrahydrofolate metabolic process (GO:0046653) | 2.62535497 |
| 139 | complement activation (GO:0006956) | 2.59874149 |
| 140 | glycoside metabolic process (GO:0016137) | 2.58009002 |
| 141 | triglyceride metabolic process (GO:0006641) | 2.55636060 |
| 142 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.54234511 |
| 143 | branched-chain amino acid metabolic process (GO:0009081) | 2.54093367 |
| 144 | acute inflammatory response (GO:0002526) | 2.53066691 |
| 145 | biotin metabolic process (GO:0006768) | 2.51139012 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.99454026 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.78848152 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.47152340 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.23460809 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.05355932 |
| 6 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.95781742 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.72279454 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.86490112 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.74316860 |
| 10 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.02461553 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.20534542 |
| 12 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05205607 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.01605263 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.00563957 |
| 15 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2907247 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.98605150 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.90451833 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84236361 |
| 19 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.82153876 |
| 20 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.78374793 |
| 21 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.78068179 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.77128191 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.74066177 |
| 24 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.69084323 |
| 25 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.65764592 |
| 26 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.63421998 |
| 27 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.62214125 |
| 28 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.60266438 |
| 29 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.53608854 |
| 30 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.51817795 |
| 31 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.48760795 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.48320391 |
| 33 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46565163 |
| 34 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46491480 |
| 35 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.43742253 |
| 36 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.43176518 |
| 37 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.39691332 |
| 38 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37576984 |
| 39 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.36934850 |
| 40 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.36678892 |
| 41 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.35076927 |
| 42 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33336039 |
| 43 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33137685 |
| 44 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.32763863 |
| 45 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.32357560 |
| 46 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.31963458 |
| 47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.29702231 |
| 48 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.28248260 |
| 49 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26471372 |
| 50 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25048548 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24160929 |
| 52 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.24159924 |
| 53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21651076 |
| 54 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.20446370 |
| 55 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.19638550 |
| 56 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18411313 |
| 57 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17681059 |
| 58 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.16770442 |
| 59 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.16232334 |
| 60 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.14907999 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13129828 |
| 62 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.12888743 |
| 63 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12596249 |
| 64 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11747187 |
| 65 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.11601924 |
| 66 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11395442 |
| 67 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10413531 |
| 68 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09941129 |
| 69 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.09598673 |
| 70 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.08517279 |
| 71 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.08224053 |
| 72 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.07580194 |
| 73 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.05953660 |
| 74 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.05233467 |
| 75 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.05167605 |
| 76 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.04947734 |
| 77 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04919074 |
| 78 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04708415 |
| 79 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04543647 |
| 80 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.03609698 |
| 81 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.02481226 |
| 82 | SPI1_23127762_ChIP-Seq_K562_Human | 1.01548210 |
| 83 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.01074331 |
| 84 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.01022120 |
| 85 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00368357 |
| 86 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.00155525 |
| 87 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.00089973 |
| 88 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.99883119 |
| 89 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99857436 |
| 90 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.99586928 |
| 91 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.99269127 |
| 92 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97796224 |
| 93 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.96058829 |
| 94 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.95889075 |
| 95 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.95277249 |
| 96 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.93614811 |
| 97 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.93192969 |
| 98 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.92350039 |
| 99 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.91388732 |
| 100 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.88036072 |
| 101 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.87272095 |
| 102 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86349543 |
| 103 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86349543 |
| 104 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.85918020 |
| 105 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85396250 |
| 106 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83918186 |
| 107 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80506092 |
| 108 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.78311852 |
| 109 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77407250 |
| 110 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72508326 |
| 111 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70105513 |
| 112 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.69933552 |
| 113 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.69683730 |
| 114 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.69675859 |
| 115 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.69060750 |
| 116 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.66886488 |
| 117 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.64776347 |
| 118 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.63877129 |
| 119 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.63738692 |
| 120 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63639133 |
| 121 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.62340131 |
| 122 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.62252968 |
| 123 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.61573279 |
| 124 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.61100047 |
| 125 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60873121 |
| 126 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.60439771 |
| 127 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.60201851 |
| 128 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.60055154 |
| 129 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.59029942 |
| 130 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.58989520 |
| 131 | CBP_21632823_ChIP-Seq_H3396_Human | 0.58888158 |
| 132 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.56594171 |
| 133 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.55901310 |
| 134 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.55185878 |
| 135 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.53669082 |
| 136 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.53392052 |
| 137 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.52869790 |
| 138 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.52596842 |
| 139 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.52190037 |
| 140 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.52041010 |
| 141 | GATA1_19941826_ChIP-Seq_K562_Human | 0.51574758 |
| 142 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.50962140 |
| 143 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.50922267 |
| 144 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50842854 |
| 145 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.50225675 |
| 146 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.50222760 |
| 147 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.48890403 |
| 148 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.48244424 |
| 149 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.48043480 |
| 150 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47348753 |
| 151 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.46988183 |
| 152 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.46165854 |
| 153 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.45627785 |
| 154 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.44681053 |
| 155 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44544088 |
| 156 | GATA2_19941826_ChIP-Seq_K562_Human | 0.43988530 |
| 157 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.43013106 |
| 158 | * EGR1_19032775_ChIP-ChIP_M12_Human | 0.42972123 |
| 159 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.42303868 |
| 160 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.41744911 |
| 161 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.40908566 |
| 162 | * P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.40028924 |
| 163 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.39953326 |
| 164 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.39941844 |
| 165 | * NCOR_22424771_ChIP-Seq_293T_Human | 0.39768886 |
| 166 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.39517557 |
| 167 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.39240143 |
| 168 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.39172728 |
| 169 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.39006388 |
| 170 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.38813893 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.04397526 |
| 2 | MP0005360_urolithiasis | 7.60990760 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.11886291 |
| 4 | MP0005365_abnormal_bile_salt | 5.88820989 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.02240664 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.36452377 |
| 7 | MP0003252_abnormal_bile_duct | 3.72587011 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.41806137 |
| 9 | MP0009840_abnormal_foam_cell | 3.17498643 |
| 10 | MP0003195_calcinosis | 3.13642413 |
| 11 | * MP0005332_abnormal_amino_acid | 2.98368992 |
| 12 | MP0005083_abnormal_biliary_tract | 2.96312931 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.50699393 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.36510802 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.33771520 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.15842825 |
| 17 | * MP0000609_abnormal_liver_physiology | 2.01832318 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.00335582 |
| 19 | MP0000343_altered_response_to | 1.78781107 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.78080283 |
| 21 | MP0003868_abnormal_feces_composition | 1.71446667 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.67104540 |
| 23 | MP0005451_abnormal_body_composition | 1.66402340 |
| 24 | MP0001545_abnormal_hematopoietic_system | 1.62528008 |
| 25 | MP0005397_hematopoietic_system_phenotyp | 1.62528008 |
| 26 | MP0001764_abnormal_homeostasis | 1.62347849 |
| 27 | * MP0009643_abnormal_urine_homeostasis | 1.44906689 |
| 28 | MP0003186_abnormal_redox_activity | 1.44278311 |
| 29 | MP0002877_abnormal_melanocyte_morpholog | 1.42341427 |
| 30 | MP0002132_abnormal_respiratory_system | 1.39507636 |
| 31 | MP0008438_abnormal_cutaneous_collagen | 1.38036618 |
| 32 | MP0003011_delayed_dark_adaptation | 1.36030719 |
| 33 | MP0003950_abnormal_plasma_membrane | 1.34775387 |
| 34 | MP0009697_abnormal_copulation | 1.27965258 |
| 35 | MP0000858_altered_metastatic_potential | 1.23967071 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.22880583 |
| 37 | MP0000372_irregular_coat_pigmentation | 1.18635482 |
| 38 | MP0000604_amyloidosis | 1.18017927 |
| 39 | MP0008007_abnormal_cellular_replicative | 1.11258700 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.10849416 |
| 41 | MP0005636_abnormal_mineral_homeostasis | 1.10099427 |
| 42 | MP0003303_peritoneal_inflammation | 1.07251681 |
| 43 | * MP0000598_abnormal_liver_morphology | 1.05734378 |
| 44 | MP0005670_abnormal_white_adipose | 1.04853930 |
| 45 | MP0005647_abnormal_sex_gland | 1.03471912 |
| 46 | MP0009785_altered_susceptibility_to | 1.03463563 |
| 47 | MP0003690_abnormal_glial_cell | 0.98714815 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 0.98131850 |
| 49 | MP0003705_abnormal_hypodermis_morpholog | 0.97588106 |
| 50 | MP0009764_decreased_sensitivity_to | 0.96860868 |
| 51 | MP0003172_abnormal_lysosome_physiology | 0.96778964 |
| 52 | MP0003436_decreased_susceptibility_to | 0.95654094 |
| 53 | MP0002419_abnormal_innate_immunity | 0.94891623 |
| 54 | MP0003329_amyloid_beta_deposits | 0.94828752 |
| 55 | MP0003566_abnormal_cell_adhesion | 0.94752999 |
| 56 | MP0002254_reproductive_system_inflammat | 0.93275041 |
| 57 | MP0006036_abnormal_mitochondrial_physio | 0.93145227 |
| 58 | MP0005408_hypopigmentation | 0.92837676 |
| 59 | MP0002876_abnormal_thyroid_physiology | 0.89689042 |
| 60 | MP0005023_abnormal_wound_healing | 0.89520556 |
| 61 | * MP0009763_increased_sensitivity_to | 0.89265944 |
| 62 | MP0005164_abnormal_response_to | 0.87174297 |
| 63 | MP0001661_extended_life_span | 0.86193298 |
| 64 | MP0004043_abnormal_pH_regulation | 0.84782715 |
| 65 | * MP0009642_abnormal_blood_homeostasis | 0.84452524 |
| 66 | MP0000003_abnormal_adipose_tissue | 0.83928799 |
| 67 | MP0005084_abnormal_gallbladder_morpholo | 0.82688084 |
| 68 | MP0008469_abnormal_protein_level | 0.82628243 |
| 69 | MP0003828_pulmonary_edema | 0.81147718 |
| 70 | MP0010368_abnormal_lymphatic_system | 0.80686356 |
| 71 | MP0001756_abnormal_urination | 0.80667802 |
| 72 | MP0002971_abnormal_brown_adipose | 0.80219851 |
| 73 | MP0005535_abnormal_body_temperature | 0.78903179 |
| 74 | MP0004130_abnormal_muscle_cell | 0.78347101 |
| 75 | MP0008004_abnormal_stomach_pH | 0.77612926 |
| 76 | MP0001853_heart_inflammation | 0.77606138 |
| 77 | MP0005376_homeostasis/metabolism_phenot | 0.77196186 |
| 78 | MP0001835_abnormal_antigen_presentation | 0.76418938 |
| 79 | MP0000371_diluted_coat_color | 0.76109534 |
| 80 | * MP0002078_abnormal_glucose_homeostasis | 0.74807303 |
| 81 | MP0005410_abnormal_fertilization | 0.74711554 |
| 82 | MP0005025_abnormal_response_to | 0.72456152 |
| 83 | * MP0001845_abnormal_inflammatory_respons | 0.70269804 |
| 84 | MP0008260_abnormal_autophagy | 0.70009997 |
| 85 | MP0001533_abnormal_skeleton_physiology | 0.69743337 |
| 86 | MP0005334_abnormal_fat_pad | 0.69735534 |
| 87 | MP0000685_abnormal_immune_system | 0.67574662 |
| 88 | MP0005666_abnormal_adipose_tissue | 0.64299455 |
| 89 | MP0005220_abnormal_exocrine_pancreas | 0.63804731 |
| 90 | * MP0009765_abnormal_xenobiotic_induced | 0.63671860 |
| 91 | MP0005167_abnormal_blood-brain_barrier | 0.62280090 |
| 92 | MP0004272_abnormal_basement_membrane | 0.62277678 |
| 93 | MP0000358_abnormal_cell_content/ | 0.62038454 |
| 94 | MP0005266_abnormal_metabolism | 0.61907777 |
| 95 | MP0000689_abnormal_spleen_morphology | 0.60382295 |
| 96 | MP0005000_abnormal_immune_tolerance | 0.59535276 |
| 97 | * MP0002136_abnormal_kidney_physiology | 0.59077643 |
| 98 | MP0000639_abnormal_adrenal_gland | 0.58090442 |
| 99 | MP0005058_abnormal_lysosome_morphology | 0.57258537 |
| 100 | MP0002837_dystrophic_cardiac_calcinosis | 0.55697414 |
| 101 | MP0006035_abnormal_mitochondrial_morpho | 0.53984508 |
| 102 | MP0005448_abnormal_energy_balance | 0.53739662 |
| 103 | MP0005395_other_phenotype | 0.52878230 |
| 104 | MP0000920_abnormal_myelination | 0.51476138 |
| 105 | MP0008874_decreased_physiological_sensi | 0.48582532 |
| 106 | MP0003638_abnormal_response/metabolism_ | 0.48021160 |
| 107 | MP0002822_catalepsy | 0.46753243 |
| 108 | MP0002796_impaired_skin_barrier | 0.46686348 |
| 109 | MP0000230_abnormal_systemic_arterial | 0.46002947 |
| 110 | MP0003075_altered_response_to | 0.45079777 |
| 111 | MP0001765_abnormal_ion_homeostasis | 0.44497330 |
| 112 | MP0003724_increased_susceptibility_to | 0.43263379 |
| 113 | MP0009053_abnormal_anal_canal | 0.42712467 |
| 114 | MP0002168_other_aberrant_phenotype | 0.42288333 |
| 115 | MP0004381_abnormal_hair_follicle | 0.42197296 |
| 116 | MP0008873_increased_physiological_sensi | 0.41607927 |
| 117 | MP0003718_maternal_effect | 0.41590112 |
| 118 | MP0003953_abnormal_hormone_level | 0.40565673 |
| 119 | MP0008872_abnormal_physiological_respon | 0.39720537 |
| 120 | MP0000579_abnormal_nail_morphology | 0.38890382 |
| 121 | MP0002928_abnormal_bile_duct | 0.38054448 |
| 122 | MP0004782_abnormal_surfactant_physiolog | 0.37387323 |
| 123 | MP0009384_cardiac_valve_regurgitation | 0.36861740 |
| 124 | MP0005464_abnormal_platelet_physiology | 0.34097749 |
| 125 | MP0002295_abnormal_pulmonary_circulatio | 0.33653342 |
| 126 | MP0006082_CNS_inflammation | 0.32879400 |
| 127 | MP0009115_abnormal_fat_cell | 0.32526648 |
| 128 | MP0009672_abnormal_birth_weight | 0.32149872 |
| 129 | MP0001881_abnormal_mammary_gland | 0.31951894 |
| 130 | MP0004185_abnormal_adipocyte_glucose | 0.31587691 |
| 131 | MP0005166_decreased_susceptibility_to | 0.30952795 |
| 132 | MP0002970_abnormal_white_adipose | 0.30232408 |
| 133 | MP0001243_abnormal_dermal_layer | 0.29981246 |
| 134 | MP0000249_abnormal_blood_vessel | 0.28957515 |
| 135 | MP0003959_abnormal_lean_body | 0.28570394 |
| 136 | MP0004147_increased_porphyrin_level | 0.28019614 |
| 137 | MP0005375_adipose_tissue_phenotype | 0.26763154 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.98479603 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.97081104 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.94188503 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.24900617 |
| 5 | Xanthomatosis (HP:0000991) | 6.15985426 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.02926367 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.81886974 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.44161832 |
| 9 | Complement deficiency (HP:0004431) | 4.92911612 |
| 10 | Hyperammonemia (HP:0001987) | 4.67638771 |
| 11 | Hyperglycinemia (HP:0002154) | 4.51000886 |
| 12 | Ketosis (HP:0001946) | 4.48724589 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.42807334 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.42662864 |
| 15 | Joint hemorrhage (HP:0005261) | 4.42379862 |
| 16 | Hyperglycinuria (HP:0003108) | 4.34152372 |
| 17 | Abnormality of glycine metabolism (HP:0010895) | 4.34016136 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.34016136 |
| 19 | Epidermoid cyst (HP:0200040) | 4.32399517 |
| 20 | Purpura (HP:0000979) | 4.17867572 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.12823985 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 4.10167528 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 3.95131071 |
| 24 | Fat malabsorption (HP:0002630) | 3.92714652 |
| 25 | * Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.88330410 |
| 26 | * Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.86895496 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.79050324 |
| 28 | Increased mean platelet volume (HP:0011877) | 3.66194741 |
| 29 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.65101296 |
| 30 | * Abnormality of methionine metabolism (HP:0010901) | 3.57141566 |
| 31 | Petechiae (HP:0000967) | 3.53946194 |
| 32 | Abnormality of complement system (HP:0005339) | 3.51698492 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.48409044 |
| 34 | Prolonged bleeding time (HP:0003010) | 3.46307132 |
| 35 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.45689673 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.43464207 |
| 37 | Abnormality of the intrinsic pathway (HP:0010989) | 3.40219190 |
| 38 | Abnormal platelet volume (HP:0011876) | 3.36558170 |
| 39 | Ketoacidosis (HP:0001993) | 3.35381893 |
| 40 | Hypercholesterolemia (HP:0003124) | 3.33937178 |
| 41 | Delayed CNS myelination (HP:0002188) | 3.22652427 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 3.15453561 |
| 43 | Hyperbilirubinemia (HP:0002904) | 3.15417248 |
| 44 | Epistaxis (HP:0000421) | 3.13405270 |
| 45 | Abnormality of serum amino acid levels (HP:0003112) | 3.11083063 |
| 46 | Gout (HP:0001997) | 3.04814629 |
| 47 | Steatorrhea (HP:0002570) | 3.02626299 |
| 48 | Abnormality of purine metabolism (HP:0004352) | 3.00335504 |
| 49 | Hypertriglyceridemia (HP:0002155) | 2.98287691 |
| 50 | Abnormal platelet function (HP:0011869) | 2.96436496 |
| 51 | Impaired platelet aggregation (HP:0003540) | 2.96436496 |
| 52 | Metabolic acidosis (HP:0001942) | 2.93701667 |
| 53 | Vascular calcification (HP:0004934) | 2.90363189 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.86198311 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.86198311 |
| 56 | Abnormality of glycolysis (HP:0004366) | 2.84084860 |
| 57 | Nausea (HP:0002018) | 2.81817153 |
| 58 | Lethargy (HP:0001254) | 2.81519925 |
| 59 | Increased serum pyruvate (HP:0003542) | 2.80491742 |
| 60 | Spontaneous abortion (HP:0005268) | 2.76136050 |
| 61 | Myocardial infarction (HP:0001658) | 2.73162665 |
| 62 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.73133089 |
| 63 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.73133089 |
| 64 | Abnormality of glycolipid metabolism (HP:0010969) | 2.73133089 |
| 65 | Cerebral edema (HP:0002181) | 2.67339205 |
| 66 | Skin nodule (HP:0200036) | 2.63450298 |
| 67 | Cardiovascular calcification (HP:0011915) | 2.58684988 |
| 68 | Vacuolated lymphocytes (HP:0001922) | 2.58591948 |
| 69 | Increased serum ferritin (HP:0003281) | 2.58152034 |
| 70 | Hepatosplenomegaly (HP:0001433) | 2.57267107 |
| 71 | Systemic lupus erythematosus (HP:0002725) | 2.55398519 |
| 72 | Vertebral compression fractures (HP:0002953) | 2.54390307 |
| 73 | Hypochromic microcytic anemia (HP:0004840) | 2.52311120 |
| 74 | Irritability (HP:0000737) | 2.50451959 |
| 75 | Generalized aminoaciduria (HP:0002909) | 2.45237281 |
| 76 | Abnormal gallbladder morphology (HP:0012437) | 2.42305566 |
| 77 | Alkalosis (HP:0001948) | 2.40059041 |
| 78 | Amyloidosis (HP:0011034) | 2.37956460 |
| 79 | Malnutrition (HP:0004395) | 2.36147271 |
| 80 | Hypoglycemic seizures (HP:0002173) | 2.35261913 |
| 81 | Spastic diplegia (HP:0001264) | 2.34670636 |
| 82 | Dysostosis multiplex (HP:0000943) | 2.34645450 |
| 83 | Cholecystitis (HP:0001082) | 2.34596622 |
| 84 | Abnormal gallbladder physiology (HP:0012438) | 2.34596622 |
| 85 | Vomiting (HP:0002013) | 2.33766845 |
| 86 | Cholelithiasis (HP:0001081) | 2.33454217 |
| 87 | * Hepatocellular carcinoma (HP:0001402) | 2.31135046 |
| 88 | Mitral stenosis (HP:0001718) | 2.30915717 |
| 89 | Rhabdomyolysis (HP:0003201) | 2.30682454 |
| 90 | Neonatal onset (HP:0003623) | 2.30028012 |
| 91 | Nephritis (HP:0000123) | 2.28163561 |
| 92 | Reduced antithrombin III activity (HP:0001976) | 2.27095347 |
| 93 | Polycythemia (HP:0001901) | 2.26369046 |
| 94 | Acanthocytosis (HP:0001927) | 2.24247194 |
| 95 | Proximal tubulopathy (HP:0000114) | 2.21166205 |
| 96 | Increased muscle lipid content (HP:0009058) | 2.20451031 |
| 97 | Glomerulonephritis (HP:0000099) | 2.19339902 |
| 98 | Pancreatitis (HP:0001733) | 2.18982708 |
| 99 | Reticulocytosis (HP:0001923) | 2.17417648 |
| 100 | Brushfield spots (HP:0001088) | 2.16821355 |
| 101 | Abnormality of proline metabolism (HP:0010907) | 2.16111844 |
| 102 | Hydroxyprolinuria (HP:0003080) | 2.16111844 |
| 103 | Opisthotonus (HP:0002179) | 2.15661674 |
| 104 | Hyperuricemia (HP:0002149) | 2.15525811 |
| 105 | Increased purine levels (HP:0004368) | 2.15525811 |
| 106 | Sensorimotor neuropathy (HP:0007141) | 2.11648112 |
| 107 | Glycosuria (HP:0003076) | 2.06346009 |
| 108 | Abnormality of urine glucose concentration (HP:0011016) | 2.06346009 |
| 109 | Poikilocytosis (HP:0004447) | 2.04878170 |
| 110 | Abnormal pupillary function (HP:0007686) | 2.04213278 |
| 111 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.03949157 |
| 112 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.03949157 |
| 113 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.03949157 |
| 114 | Mucopolysacchariduria (HP:0008155) | 2.02515426 |
| 115 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.02515426 |
| 116 | Late onset (HP:0003584) | 2.02040000 |
| 117 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.99018337 |
| 118 | Hemorrhage of the eye (HP:0011885) | 1.98821599 |
| 119 | Esophageal varix (HP:0002040) | 1.97136351 |
| 120 | Abnormality of the gallbladder (HP:0005264) | 1.96751866 |
| 121 | Gingival bleeding (HP:0000225) | 1.94340214 |
| 122 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.92979179 |
| 123 | Abnormality of alanine metabolism (HP:0010916) | 1.92085183 |
| 124 | Hyperalaninemia (HP:0003348) | 1.92085183 |
| 125 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.92085183 |
| 126 | Hepatic necrosis (HP:0002605) | 1.90216263 |
| 127 | Menorrhagia (HP:0000132) | 1.89250384 |
| 128 | Prolonged neonatal jaundice (HP:0006579) | 1.89022699 |
| 129 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.88883399 |
| 130 | Acute encephalopathy (HP:0006846) | 1.87361726 |
| 131 | Thrombophlebitis (HP:0004418) | 1.86132342 |
| 132 | Increased cerebral lipofuscin (HP:0011813) | 1.86009106 |
| 133 | Abnormal cartilage morphology (HP:0002763) | 1.84954645 |
| 134 | Abnormality of vitamin metabolism (HP:0100508) | 1.84754330 |
| 135 | Type I transferrin isoform profile (HP:0003642) | 1.82640500 |
| 136 | * Rickets (HP:0002748) | 1.81812413 |
| 137 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81805122 |
| 138 | Abnormality of iron homeostasis (HP:0011031) | 1.81802141 |
| 139 | * Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.81422005 |
| 140 | Confusion (HP:0001289) | 1.80094428 |
| 141 | Renal cortical cysts (HP:0000803) | 1.79121691 |
| 142 | Abnormality of the Achilles tendon (HP:0005109) | 1.76559545 |
| 143 | Elevated alkaline phosphatase (HP:0003155) | 1.75992976 |
| 144 | Back pain (HP:0003418) | 1.75213850 |
| 145 | Acanthosis nigricans (HP:0000956) | 1.74329964 |
| 146 | Increased intramyocellular lipid droplets (HP:0012240) | 1.73529130 |
| 147 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.72349280 |
| 148 | Hypertensive crisis (HP:0100735) | 1.69811066 |
| 149 | Thrombocytosis (HP:0001894) | 1.69444272 |
| 150 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.69066263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.19600810 |
| 2 | SIK1 | 4.14457439 |
| 3 | FGFR4 | 4.13234000 |
| 4 | NME2 | 3.67843826 |
| 5 | ERN1 | 3.65103336 |
| 6 | EIF2AK1 | 2.97063880 |
| 7 | INSRR | 2.90414753 |
| 8 | ERBB4 | 2.68666511 |
| 9 | TESK1 | 2.38250974 |
| 10 | OXSR1 | 2.30704951 |
| 11 | EPHB1 | 2.29365443 |
| 12 | VRK2 | 2.29212930 |
| 13 | TAOK3 | 2.23306045 |
| 14 | MYLK | 2.14873713 |
| 15 | STK39 | 2.13969771 |
| 16 | TAOK2 | 2.13217389 |
| 17 | MST1R | 2.11878975 |
| 18 | WNK4 | 2.11748511 |
| 19 | PIM2 | 2.09496623 |
| 20 | FGFR2 | 1.97413490 |
| 21 | SCYL2 | 1.94672767 |
| 22 | MAPKAPK3 | 1.83700657 |
| 23 | MAP2K4 | 1.83576826 |
| 24 | MST4 | 1.81420565 |
| 25 | MET | 1.76361802 |
| 26 | TESK2 | 1.62904398 |
| 27 | ARAF | 1.61876595 |
| 28 | MAPK11 | 1.55353184 |
| 29 | RIPK4 | 1.49568317 |
| 30 | ILK | 1.48544211 |
| 31 | PIK3CG | 1.45614007 |
| 32 | ABL2 | 1.45064512 |
| 33 | LATS1 | 1.36605020 |
| 34 | STK16 | 1.35379243 |
| 35 | TRIB3 | 1.34650977 |
| 36 | DAPK2 | 1.30829094 |
| 37 | PKN2 | 1.30548074 |
| 38 | PINK1 | 1.28904088 |
| 39 | FLT3 | 1.27847280 |
| 40 | PAK4 | 1.25797249 |
| 41 | MATK | 1.22150881 |
| 42 | WNK3 | 1.19842135 |
| 43 | TYK2 | 1.17799808 |
| 44 | SMG1 | 1.17618484 |
| 45 | PTK6 | 1.17451570 |
| 46 | IKBKB | 1.16371566 |
| 47 | PKN1 | 1.15750403 |
| 48 | PRPF4B | 1.14542686 |
| 49 | PRKAA2 | 1.13637047 |
| 50 | BUB1 | 1.12248654 |
| 51 | MAP3K7 | 1.09423028 |
| 52 | DAPK3 | 1.08753217 |
| 53 | ZAP70 | 1.04746996 |
| 54 | KDR | 1.04276583 |
| 55 | STK38L | 1.00440056 |
| 56 | JAK2 | 0.98387672 |
| 57 | SGK494 | 0.97969541 |
| 58 | SGK223 | 0.97969541 |
| 59 | PBK | 0.96820401 |
| 60 | MAPK15 | 0.95348193 |
| 61 | BMPR2 | 0.94843422 |
| 62 | PAK1 | 0.93475790 |
| 63 | CAMK2G | 0.92797638 |
| 64 | NEK9 | 0.92089758 |
| 65 | TIE1 | 0.91545698 |
| 66 | BLK | 0.90170631 |
| 67 | JAK3 | 0.89135389 |
| 68 | CLK1 | 0.89001945 |
| 69 | GSK3A | 0.88994163 |
| 70 | CAMK1D | 0.87886610 |
| 71 | DDR2 | 0.87317880 |
| 72 | PRKCZ | 0.85918462 |
| 73 | VRK1 | 0.85134678 |
| 74 | ERBB2 | 0.83822659 |
| 75 | GRK6 | 0.83432414 |
| 76 | FRK | 0.83197589 |
| 77 | MUSK | 0.81375518 |
| 78 | MAPK4 | 0.80512662 |
| 79 | CSNK1G1 | 0.79570435 |
| 80 | MAPK12 | 0.77795151 |
| 81 | PDPK1 | 0.77678797 |
| 82 | BTK | 0.77379990 |
| 83 | KIT | 0.77207696 |
| 84 | EIF2AK3 | 0.77036122 |
| 85 | TLK1 | 0.75459824 |
| 86 | JAK1 | 0.73915147 |
| 87 | MAP3K14 | 0.73757488 |
| 88 | PRKACG | 0.72920973 |
| 89 | MAP3K8 | 0.72117635 |
| 90 | TRPM7 | 0.71230359 |
| 91 | EPHA3 | 0.71153916 |
| 92 | TEC | 0.68626845 |
| 93 | TBK1 | 0.68391302 |
| 94 | PRKCQ | 0.67454716 |
| 95 | PTK2 | 0.65675325 |
| 96 | CSNK1G3 | 0.64925465 |
| 97 | ICK | 0.64216966 |
| 98 | CCNB1 | 0.63267217 |
| 99 | GRK5 | 0.63081575 |
| 100 | CSK | 0.60310064 |
| 101 | TNK2 | 0.59900084 |
| 102 | PRKAA1 | 0.59363649 |
| 103 | SYK | 0.59295164 |
| 104 | EPHA4 | 0.58371887 |
| 105 | CDK9 | 0.58230343 |
| 106 | MAP2K3 | 0.57449659 |
| 107 | PAK3 | 0.57079157 |
| 108 | CSNK1A1L | 0.56578223 |
| 109 | DAPK1 | 0.56115519 |
| 110 | NUAK1 | 0.56013418 |
| 111 | NTRK1 | 0.55274877 |
| 112 | PDK3 | 0.54898210 |
| 113 | PDK4 | 0.54898210 |
| 114 | MAP3K3 | 0.54805533 |
| 115 | DYRK1B | 0.54802255 |
| 116 | PAK2 | 0.54689365 |
| 117 | NEK1 | 0.54612264 |
| 118 | CAMK1G | 0.54602846 |
| 119 | CDK7 | 0.53336024 |
| 120 | CSNK1G2 | 0.52232133 |
| 121 | ZAK | 0.51798224 |
| 122 | MAPK7 | 0.49351253 |
| 123 | CDK8 | 0.49351003 |
| 124 | MAP3K13 | 0.49258547 |
| 125 | SGK3 | 0.48582292 |
| 126 | RPS6KB2 | 0.48142597 |
| 127 | LMTK2 | 0.45911616 |
| 128 | MOS | 0.44965714 |
| 129 | TTK | 0.42822780 |
| 130 | MAP3K11 | 0.42309679 |
| 131 | CSF1R | 0.41325827 |
| 132 | LIMK1 | 0.41185749 |
| 133 | RAF1 | 0.40926600 |
| 134 | MAP2K1 | 0.40898496 |
| 135 | PDK1 | 0.40748406 |
| 136 | FER | 0.40064816 |
| 137 | AURKA | 0.39851295 |
| 138 | RET | 0.39783523 |
| 139 | LYN | 0.39655983 |
| 140 | IGF1R | 0.39359384 |
| 141 | IRAK2 | 0.39328075 |
| 142 | MAP2K2 | 0.38697121 |
| 143 | EEF2K | 0.38393817 |
| 144 | STK4 | 0.38374642 |
| 145 | TGFBR2 | 0.38209743 |
| 146 | MAP2K6 | 0.37996948 |
| 147 | GRK1 | 0.37902167 |
| 148 | PRKD1 | 0.37559987 |
| 149 | CDK6 | 0.36434927 |
| 150 | BMX | 0.36398174 |
| 151 | IRAK1 | 0.35073076 |
| 152 | MAPKAPK5 | 0.35028965 |
| 153 | AKT2 | 0.34511850 |
| 154 | BRAF | 0.33489322 |
| 155 | RIPK1 | 0.32251157 |
| 156 | CAMK2B | 0.31625188 |
| 157 | IRAK3 | 0.30176730 |
| 158 | PDK2 | 0.29874381 |
| 159 | PRKCG | 0.29387143 |
| 160 | PIK3CA | 0.29226290 |
| 161 | BCR | 0.28982773 |
| 162 | SGK2 | 0.28450957 |
| 163 | PRKCA | 0.27958824 |
| 164 | IKBKE | 0.27770666 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.18414425 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.45483101 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.20599238 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.17148159 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.90061387 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.81766402 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.70149008 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.63718494 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.60613243 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.59317113 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50282848 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.48497222 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.38817692 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.18835413 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.17251569 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.16843298 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09510483 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.05736123 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.96332583 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.94005917 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88691691 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.85888341 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.84668816 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.83938028 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.74996915 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.70128805 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.69934118 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.61461331 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.60443082 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.60311380 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.59563250 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.57768644 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.56863191 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.56272668 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54118686 |
| 36 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.53466440 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.52746525 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.52260083 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.46296777 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.43636802 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.42379903 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25765723 |
| 43 | * Tyrosine metabolism_Homo sapiens_hsa00350 | 1.24417228 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22885547 |
| 45 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.22739209 |
| 46 | Proteasome_Homo sapiens_hsa03050 | 1.19820544 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.19471405 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16798310 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15810101 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.12633331 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.10146145 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09267116 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.08814148 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00236776 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.99754869 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.95979441 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91787024 |
| 58 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.88536035 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86211466 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.78442635 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.76999336 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75958715 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75650011 |
| 64 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.69500739 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68455444 |
| 66 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.67709874 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.61567818 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60917400 |
| 69 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.60172752 |
| 70 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.59992155 |
| 71 | DNA replication_Homo sapiens_hsa03030 | 0.56330301 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53646077 |
| 73 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53588274 |
| 74 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.50450138 |
| 75 | Mismatch repair_Homo sapiens_hsa03430 | 0.48154589 |
| 76 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.43771645 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42510016 |
| 78 | Base excision repair_Homo sapiens_hsa03410 | 0.41381745 |
| 79 | Parkinsons disease_Homo sapiens_hsa05012 | 0.38695083 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38452329 |
| 81 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.34369541 |
| 82 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.33896724 |
| 83 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.33342451 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.32851543 |
| 85 | Prion diseases_Homo sapiens_hsa05020 | 0.28812929 |
| 86 | Pertussis_Homo sapiens_hsa05133 | 0.27643877 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25408955 |
| 88 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22910561 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.22320484 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21818963 |
| 91 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.21511482 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20355735 |
| 93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.19860875 |
| 94 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.18729938 |
| 95 | RNA polymerase_Homo sapiens_hsa03020 | 0.17816797 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.17576670 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.16720174 |
| 98 | Purine metabolism_Homo sapiens_hsa00230 | 0.15050072 |
| 99 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.10959203 |
| 100 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.08579438 |
| 101 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03311040 |
| 102 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.02897988 |
| 103 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.00390700 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.2257495 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2195955 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2122823 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1957371 |
| 108 | Hepatitis C_Homo sapiens_hsa05160 | -0.1872779 |
| 109 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1763690 |
| 110 | Lysosome_Homo sapiens_hsa04142 | -0.1681782 |
| 111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1630287 |
| 112 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1605879 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | -0.1576458 |
| 114 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1562239 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1524490 |
| 116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1452796 |
| 117 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.1367360 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1352443 |
| 119 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1307932 |
| 120 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1091883 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0350418 |
| 122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0333515 |

